The JPML found that NAION cases share common factual questions involving: Drug development and clinical testing Marketing and promotional practices Labeling and warning decisions Regulatory history and FDA interactions Scientific evidence linking GLP-1 drugs to optic nerve injury Because the medical mechanisms, risk profiles, and damages associated with permanent vision loss differ significantly from those of gastrointestinal claims, the court concluded that combining them would be inefficient and potentially unfair to plaintiffs
Documented synergy between GHRH and GHRPs has been demonstrated across multiple species and experimental systems, supporting the generality of the phenomenon, but the magnitude of synergistic enhancement varies between studies and may depend on dose ratios, timing, baseline GH status, and other factors
Side Effects of GLP-1 GLP-1 medications may cause side effects, most commonly gastrointestinal (GI) issues such as nausea, vomiting, diarrhea, constipation, and dizziness
Saxenda: Dual Action and Daily Dosing Mounjaro: This is a newer dual-action medication
2021;44:S15167
How is Glutathione administered